← Open Payments lookup

WANDA CAESAR: Open Payments

NPI 1316288699 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,002 in 77 payments from 11 companies in 2025. Trend: 2023 $839 · 2024 $564 · 2025 $2,002

Food & beverage: $2,002
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.12$385
E.R. Squibb & Sons, L.L.C.14$290
Alkermes, Inc.14$248
Janssen Pharmaceuticals, Inc6$247
Neurocrine BioSciences, Inc.8$206
Otsuka America Pharmaceutical, Inc.8$189
bioMerieux Inc1$162
Teva Pharmaceuticals USA, Inc.4$82
Lundbeck LLC4$81
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$61

Products named: FANAPT, COBENFY, ARISTADA, INVEGA SUSTENNA, INGREZZA, ABILIFY ASIMTUFII, REXULTI, HETLIOZ.

Industry payments across MD — which companies pay providers there.